Sarepta Therapeutics,, Inc. (SRPT) Revenue by Year

SRPT

Sarepta Therapeutics,, Inc. generated $2.2B in revenue in fiscal year 2025. This represents an increase of 15.6% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $2.0B in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Sarepta Therapeutics,, Inc. has filed alongside them.

FY2025 annual

Revenue $2.2B

YoY +15.6%

5Y CAGR +32.4%

10Y CAGR +111.1%

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 5, 2026 Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SRPT Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$2.0B	$2.2B+15.6%	$1.9B+53.0%	$1.2B+33.3%	$933.0M+32.9%	$701.9M+30.0%	$540.1M+41.8%	$380.8M+26.5%	$301.0M+94.7%	$154.6M+2751.6%	$5.4M+332.6%	$1.3M-87.2%	$9.8M	N/A	N/A	N/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

SRPT Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K	Q2'2410-K	Q1'2410-K	Q4'2310-K	Q3'2310-Q
Revenue	$401.3M-34.3%	$730.8M-1.9%	$442.9M-32.7%	$399.4M-14.5%	$611.1M+68.4%	$744.9M+80.2%	$658.4M+65.9%	$467.2M+40.8%	$362.9M+38.9%	$413.5M+63.1%	$396.8M+53.5%	$331.8M+44.1%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Sarepta Therapeutics,, Inc. financials

Frequently Asked Questions

What was Sarepta Therapeutics,, Inc.'s revenue in fiscal year 2025?

Sarepta Therapeutics,, Inc. generated $2.2B in revenue in fiscal year 2025.

How fast is Sarepta Therapeutics,, Inc.'s revenue growing?

Sarepta Therapeutics,, Inc. (SRPT) revenue rose by 15.6% year over year, from $1.9B to $2.2B in fiscal year 2025.

What is Sarepta Therapeutics,, Inc.'s revenue over the last twelve months?

Sarepta Therapeutics,, Inc. (SRPT) reported $2.0B in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

What was Sarepta Therapeutics,, Inc.'s revenue in the most recent quarter?

Sarepta Therapeutics,, Inc. (SRPT) reported $401.3M in revenue in Q2 2026. This represents a decrease of 34.3% from the same quarter a year earlier.

What does revenue mean on a financial statement?

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Sarepta Therapeutics,, Inc. (SRPT) reported on that line in every period on record.